The Bionic Ear Market Size was valued at USD 2.79 billion in 2023, and expected to reach USD 5.07 billion by 2031, and grow at a CAGR of 8.47% over the forecast period 2024-2031.
An electronic device known as a neural prosthesis, or bionic ear, is created for those who have hearing loss. It has the ability to activate the hearing nerve and deliver sound impulses right to the brain. The bionic ear consists of an external sound processor and a receiver-stimulator that are both fitted behind the ear. The sound processor also records outside sound and transforms it into a digital code. The receiver-stimulator mounted behind the ear receives this digital code and transmits it. Additionally, using the digital code it has just received, the receiver creates the electrical impulses before sending them to the electrode array located inside the cochlea. Both those who have experienced entire loss or significant loss may use these gadgets.
Get more information on Bionic Ear Market - Request Sample Report
DRIVERS
Increasing number of hearing disorders
Growing interest in minimally invasive surgical methods will help the market.
Increasing R&D expenditures to create sound processors of the future
An increase in parental knowledge and the availability of infrastructure for identifying hearing problems in newborn children
RESTRAINTS
A legal requirement
OPPORTUNITIES
Rise in research and development for bionic ears
CHALLENGES
High costs for devices and medical care
The bionic ear market was negatively influenced by COVID-19. The epidemic led to many lockdown procedures and increased difficulties for patients with hearing impairments. To treat patients with the coronavirus, many hospitals curtailed elective operations and surgeries and redistributed hospital resources like nursing staff and ICU beds. The development of the market for bionic ears was further constrained by treatment restrictions and a drop in implanted bionics production.
By Device Type
Cochlear implants, bone-anchored hearing aids, and auditory brainstem implants, are the three market segments for bionic ears. The cochlear implant market category retained a large market share. Research shows that cochlear implants are more effective than conventional devices. These gadgets improve the sound quality, making it easier for a person to comprehend conversation. Additionally, it aids in restoring clear sound in a noisy setting and is even thought to be child-safe.
These are the only medical procedures that, with electric stimulation of the remaining auditory nerve, can partially restore hearing to a deafened person. When wearing hearing aids is no longer effective and a person suffers from serious inner-ear damage, it may be a viable choice. Someone who is profoundly deaf due to retro cochlear hearing loss can now hear thanks to an electronic gadget that was surgically placed. The "processor," which is worn on the ear, is one of two components that make up an auditory brainstem implant. The other component is internal and is inserted surgically. A microphone on the processor additionally picks up the sound surrounding it and transforms it into an electrical signal. Following that, the processor transmits the sound signal to the hearing implant's internal component. An implant array is implanted inside the brainstem, while a receiver is situated immediately below the epidermis.
It is a hearing aid that employs the bone conduction theory of operation. It is intended for persons who otherwise cannot wear "in the ear" or "behind the ear" hearing aids due to unilateral hearing loss, conductive hearing loss, single-sided deafness, or combined hearing losses.
By End User
Hospitals, hearing clinics, and research institutes make up the three market segments for bionic ears. The market is expected to expand as a result of rising healthcare costs and rising demand for bionic ears. Institutions that carry out numerous studies on various topics are referred to as research institutes. Over the past few years, more research has been done on bionic ears. Research institutes are expanding as a result of increased financing for research initiatives. Rising financing for research initiatives has also resulted in an increase of research institutes, which has helped the segment's expansion.
Due to the specialist care and innovation of the facilities, hearing clinics are anticipated to expand dramatically.
The market leader and owner of the biggest market share for bionic ears was the hospital sector. More patients seek treatment at hospitals because they offer superior care and employ qualified medical personnel.
By Device Type
Cochlear Implant
Auditory Brainstem Implants
Bone-Anchored Hearing Aid
By End User
Research Institutes
Hearing Clinics
Hospitals
.png)
Need any customization research on Bionic Ear Market - Enquiry Now
The market for bionic ears in North America is the most appealing. This is caused by increased public awareness and improved diagnostic tools.
The expansion is anticipated to be fueled by bionic ear technology. Europe comes next after that. Due to its enormous population and rising affluence, the Asia-Pacific region is predicted to have the quickest growth rate.
REGIONAL COVERAGE
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are Advanced Bionics, Cochlear, Edward Lifesciences Corporation, Hangzhou Nurotron, Ekso Bionics, Medtronic PLC, Oticon, MED-EL, Listent Medical, Sonova, WS Audiology and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 2.79 Billion |
| Market Size by 2031 | US$ 5.07 Billion |
| CAGR | CAGR of 8.47% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Device Type (Cochlear Implant, Auditory Brainstem Implants, Bone-Anchored Hearing Aid) • By End User (Research Institutes, Hearing Clinics, Hospitals) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Advanced Bionics, Cochlear, Edward Lifesciences Corporation, Hangzhou Nurotron, Ekso Bionics, Medtronic PLC, Oticon, MED-EL, Listent Medical, Sonova, WS Audiology. |
| Key Drivers | • Increasing number of hearing disorders • Growing interest in minimally invasive surgical methods will help the market. |
| RESTRAINTS | • A legal requirement |
Ans. The Bionic Ear Market Size was valued at USD 2.2 billion in 2022, and expected to reach USD 4.19 billion by 2030, and grow at a CAGR of 8.4% over the forecast period 2023-2030.
Ans. The cochlear implant market category retained a large market share.
Ans. Key drivers of the Bionic Ear Market is Increasing number of hearing disorders, and Growing interest in minimally invasive surgical methods will help the market.
Ans. The bionic ear market was negatively influenced by COVID-19. The epidemic led to many lockdown procedures and increased difficulties for patients with hearing impairments
Ans. Top-down, bottom-up, Quantitative, Qualitative Research, Descriptive, Analytical, Applied, Fundamental Research.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Bionic Ear Market Segmentation, By Device Type
8.1 Cochlear Implant
8.2 Auditory Brainstem Implants
8.3 Bone-Anchored Hearing Aid
9. Bionic Ear Market Segmentation, By End User
9.1 Research Institutes
9.2 Hearing Clinics
9.3 Hospitals
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 USA
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 South Korea
10.4.3 China
10.4.4 India
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.1 Israel
10.5.2 UAE
10.5.3 South Africa
10.5.4 Rest
10.6 Latin America
10.6.1 Brazil
10.6.2 Argentina
10.6.3 Rest of Latin America
11. Company Profiles
11.1 Advanced Bionics
11.1.1 Financial
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Cochlear
11.3 Edward Lifesciences Corporation
11.4 Hangzhou Nurotron
11.5 Ekso Bionics
11.6 Medtronic PLC
11.7 Oticon
11.8 MED-EL
11.9 Listent Medical
11.10 Sonova
12. Competitive Landscape
12.1 Competitive Benchmark
12.2 Market Share Analysis
12.3 Recent Developments
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Blood Pressure Monitors was valued at USD 4.3 Bn in 2022 and is estimated to reach USD 8.69 Bn by 2030 with a CAGR of 9.2% over the forecast period of 2023-2030.
The Cancer Registry Software Market Size was valued at USD 75.45 billion in 2022, and is expected to reach USD 171.39 billion by 2030 and grow at a CAGR of 10.8% over the forecast period 2023-2030.
The Dental Implants Market size was estimated USD 5 billion in 2023 and is expected to reach USD 10.64 billion by 2031 at a CAGR of 9.9% during the forecast period of 2024-2031.
The Brain Tumor Drugs Market was estimated at US$ 2.9 billion in 2022 and is expected to reach US$ 5.73 billion by 2030. and is anticipated to increase at a CAGR of 8.9% predicted for the forecast period of 2022-2030.
The Radiotherapy Market size was estimated USD 6.79 billion in 2023 and is expected to reach USD 10.19 billion by 2031 at a CAGR of 5.53% during the forecast period of 2024-2031.
The Recombinant Vaccines Market size was USD 9.18 Billion in 2022 and is expected to Reach USD 21.46 Billion by 2030 and grow at a CAGR of 11.2% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
